Katherine Y. Look

Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian Cancer

William P. McGuire, William J. Hoskins, Mark F. Brady et al. · New England Journal of Medicine · 1996 · 2.9K citations · Full text

Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240)

Krishnansu S. Tewari, Michael W. Sill, Richard T. Penson et al. · The Lancet · 2017 · 656 citations · Full text

Advanced Cervical Cancer, Cervical Cancer Management, Cervical Cancer +11

Phase III Trial of Doxorubicin Plus Cisplatin With or Without Paclitaxel Plus Filgrastim in Advanced Endometrial Carcinoma: A Gynecologic Oncology Group Study

Gini F. Fleming, Virginia L. Brunetto, David Cella et al. · Journal of Clinical Oncology · 2004 · 561 citations · Full text

Randomized phase III trial of three versus six cycles of adjuvant carboplatin and paclitaxel in early stage epithelial ovarian carcinoma: A Gynecologic Oncology Group study

Jeffrey G. Bell, Mark F. Brady, Robert C. Young et al. · Gynecologic Oncology · 2006 · 305 citations

Adjuvant Carboplatin, Versus Six, Medicine +9

Prevalence of defective DNA mismatch repair and MSH6 mutation in an unselected series of endometrial cancers

Paul J. Goodfellow, Barbara M. Buttin, Thomas J. Herzog et al. · Proceedings of the National Academy of Sciences · 2003 · 237 citations · Full text

Epigenetic Change, Genetics, Gynecology +16